Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Interferon Cytokine Res ; 19(6): 687-91, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10433371

RESUMEN

We used the recombinant chicken interferon-gamma (ChIFN-gamma) to determine its in vitro effects on chicken immune cells. We found that ChIFN-gamma induced nitric oxide (NO) production, upregulated Ia expression on the cell surface, and inhibited the replication of Newcastle disease virus in NCSU and HD11 cells (chicken macrophage cell lines). In addition, ChIFN-gamma had an antiproliferative effect on RP9 cells, a chicken B cell line. Finally, ChIFN-gamma inhibited mitogenic proliferation of normal chicken spleen cells and induced the cells to generate NO. Inhibition of viral replication and mitogenic proliferation of normal cells were correlated with NO production. We conclude that recombinant chicken ChIFN-gamma modulates chicken immune cells.


Asunto(s)
Interferón gamma/farmacología , Macrófagos/efectos de los fármacos , Animales , División Celular/efectos de los fármacos , Pollos , Proteínas Recombinantes , Bazo/citología , Bazo/efectos de los fármacos
2.
Vaccine ; 16(16): 1496-503, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9711795

RESUMEN

We have constructed recombinant (r) fowl pox viruses (FPVs) coexpressing chicken type I interferon (IFN) and/or hemagglutinin-neuraminidase (HN) and fusion (F) proteins of Newcastle disease virus (NDV). We administered rFPVs and FPV into embryonated chicken eggs at 17 days of embryonation or in chickens after hatch. Administration of FPV or rFPVs did not influence hatchability and survival of hatched chicks. In ovo or after hatch vaccination of chickens with the recombinant viruses resulted in protection against challenge with virulent FPV and NDV. Chickens vaccinated with FPV or FPV-NDV recombinant had significantly lower body weight 2 weeks following vaccination. This loss in body weight was not detected in chickens receiving FPV-IFN and FPV-NDV-IFN recombinants. Chickens vaccinated with FPV coexpressing IFN and NDV genes produced less antibodies against NDV in comparison with chickens vaccinated with FPV expressing NDV genes.


Asunto(s)
Virus de la Viruela de las Aves de Corral/genética , Virus de la Viruela de las Aves de Corral/inmunología , Viruela Aviar/prevención & control , Proteína HN/inmunología , Interferón Tipo I/genética , Interferón Tipo I/inmunología , Enfermedad de Newcastle/prevención & control , Virus de la Enfermedad de Newcastle/genética , Virus de la Enfermedad de Newcastle/inmunología , Vacunas Sintéticas/genética , Vacunas Sintéticas/uso terapéutico , Animales , Formación de Anticuerpos , Peso Corporal , Embrión de Pollo , Pollos , Virus de la Viruela de las Aves de Corral/metabolismo , Expresión Génica , Proteína HN/biosíntesis , Proteína HN/genética , Interferón Tipo I/biosíntesis , Virus de la Enfermedad de Newcastle/metabolismo , Proteínas Virales de Fusión/biosíntesis , Proteínas Virales de Fusión/genética , Proteínas Virales de Fusión/inmunología
3.
Dev Biol Stand ; 82: 137-45, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7958468

RESUMEN

The safety and efficacy of a fowlpox-Newcastle disease vaccine were evaluated by in vitro and in vivo methods. Genetic and phenotypic stability following cell culture and chick passage were demonstrated. The safety characteristics of the recombinant virus equalled or exceeded those of the parent fowlpox virus, as determined by lack of shed and spread to contacts, failure to revert to virulence following passage in chicks and innocuity in other avian species. The fowlpox-Newcastle Disease virus effectively immunized against virulent fowlpox challenge and virulent Newcastle disease challenge (intramuscular or intra-ocular administration). These results indicate that the recombinant FPV/NDV virus is a safe and effective vaccine for poultry.


Asunto(s)
Virus Defectuosos/inmunología , Virus de la Viruela de las Aves de Corral/inmunología , Vectores Genéticos , Enfermedad de Newcastle/prevención & control , Virus de la Enfermedad de Newcastle/inmunología , Enfermedades de las Aves de Corral/prevención & control , Vacunación/veterinaria , Vacunas Sintéticas , Vacunas Virales , Animales , Pollos , Coturnix , Virus Defectuosos/genética , Ojo , Virus de la Viruela de las Aves de Corral/genética , Virus de la Viruela de las Aves de Corral/patogenicidad , Proteína HN/inmunología , Inyecciones , Inyecciones Intramusculares , Fenotipo , Seguridad , Especificidad de la Especie , Pavos , Vacunas Atenuadas , Vacunas Sintéticas/efectos adversos , Vacunas Sintéticas/inmunología , Proteínas Virales de Fusión/inmunología , Vacunas Virales/administración & dosificación , Vacunas Virales/efectos adversos , Vacunas Virales/inmunología , Virulencia
4.
Mol Gen Genet ; 203(1): 101-9, 1986 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3012276

RESUMEN

Initiation of DNA replication from the Escherichia coli origin, oriC, is dependent on an RNA polymerase-mediated transcription event. The function of this RNA synthetic event in initiation, however, remains obscure. Since control of the synthesis of this RNA could serve a key role in the overall initiation process, transcription regulatory sites within and near oriC were identified using the galK fusion vector system. Our results confirm the existence of a transcription termination signal within oriC, first identified by Hansen et al. (1981), for the 16 kd transcript that is transcribed counterclockwise towards oriC. Termination is shown to be 92% efficient. A similar approach led to the detection of transcription termination within the chromosomal replication origin of Klebsiella pneumoniae. Approximately 50% of the E. coli 16 kd transcripts appear to terminate before reaching oriC between the XhoI (+416 bp) and the HindIII (+243 bp) sites. The predominant 3' ends of RNA that enter oriC, as determined by SI nuclease mapping, were located at positions +20 +/- 2, +23 +/- 2, +37, +39, +52, +66, +92, and +107. These termination sites, which map cl to RNA . DNA junctions identified by Kohara et al. (1985), appear as triplets and quadruplets. The E. coli oriC Pori-L promoter described in in vitro transcription studies by Lother and Messer (1981) was not detected in this study in either wildtype cells or isogenic dnaA mutants at the nonpermissive temperature. A new promoter activity, Pori-R1, was identified within the E. coli origin in the clockwise direction.


Asunto(s)
Replicación del ADN , Escherichia coli/genética , Galactoquinasa/genética , Genes Reguladores , Regiones Terminadoras Genéticas , Transcripción Genética , Enzimas de Restricción del ADN , Galactoquinasa/metabolismo , Genes , Genes Bacterianos , Genotipo , Plásmidos , Regiones Promotoras Genéticas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...